Search Results

There are 3699 results for: content related to: Case of prednisolone-induced hepatitis in a patient with ulcerative colitis

  1. Comparative study on novel test systems to determine disintegration time of orodispersible films

    Journal of Pharmacy and Pharmacology

    Maren Preis, Dorothee Gronkowsky, Dominik Grytzan and Jörg Breitkreutz

    Article first published online : 27 MAR 2014, DOI: 10.1111/jphp.12246

  2. Duration of Erection: Does It Really Matter? A Randomized, Double-Blind Clinical Trial to Assess the Impact of Vardenafil ODT on Duration of Erection and Its Correlation with Patients' and Partners' Sexual Quality of Life and Duration of Intercourse: The VADEOPEN Study

    The Journal of Sexual Medicine

    Antonio Martin-Morales, Pedro Gutiérrez-Hernández, Javier Romero-Otero, José A. Romero-Martín and on behalf of the Vadeopen Study Group

    Article first published online : 13 MAR 2014, DOI: 10.1111/jsm.12496

  3. Time to Onset of Action of Vardenafil: A Retrospective Analysis of the Pivotal Trials for the Orodispersible and Film-Coated Tablet Formulations

    The Journal of Sexual Medicine

    Volume 8, Issue 10, October 2011, Pages: 2912–2923, Frans M.J. Debruyne, Marc Gittelman, Herbert Sperling, Matthias Börner and Manfred Beneke

    Article first published online : 30 AUG 2011, DOI: 10.1111/j.1743-6109.2011.02462.x

  4. You have free access to this content
    The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction

    International Journal of Clinical Practice

    Volume 64, Issue 5, April 2010, Pages: 594–603, M. Gittelman, C. G. McMahon, J. A. Rodríguez-Rivera, M. Beneke, E. Ulbrich and S. Ewald

    Article first published online : 4 MAR 2010, DOI: 10.1111/j.1742-1241.2010.02358.x

  5. The POTENT I Randomized Trial: Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 7, Issue 4pt1, April 2010, Pages: 1497–1507, Herbert Sperling, Frans Debruyne, Antonius Boermans, Manfred Beneke, Ernst Ulbrich and Silke Ewald

    Article first published online : 3 MAR 2010, DOI: 10.1111/j.1743-6109.2010.01806.x

  6. Efficacy and Safety of an Orodispersible Vardenafil Formulation for the Treatment of Erectile Dysfunction in Elderly Men and Those with Underlying Conditions: An Integrated Analysis of Two Pivotal Trials

    The Journal of Sexual Medicine

    Volume 8, Issue 1, January 2011, Pages: 261–271, Herbert Sperling, Marc Gittelman, Christiane Norenberg, Ernst Ulbrich and Silke Ewald

    Article first published online : 30 AUG 2010, DOI: 10.1111/j.1743-6109.2010.02005.x

  7. How to Evaluate the Efficacy of the Phosphodiesterase Type 5 Inhibitors

    The Journal of Sexual Medicine

    Volume 9, Issue 1, January 2012, Pages: 26–33, Emmanuele A. Jannini, Leonard R. DeRogatis, Eric Chung and Gerald B. Brock

    Article first published online : 4 JAN 2012, DOI: 10.1111/j.1743-6109.2011.02611.x

  8. Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1-year European observational study

    Human Psychopharmacology: Clinical and Experimental

    Volume 27, Issue 3, May 2012, Pages: 284–294, Susanne Kraemer, Florence Chartier, Béatrice Augendre-Ferrante, Vassiliki Psarra, Yulia D'yachkova, Anke Beselin and Fréderic Rouillon

    Article first published online : 31 MAR 2012, DOI: 10.1002/hup.2224

  9. You have free access to this content
    Cochrane Review: Sublingual immunotherapy for treating allergic conjunctivitis

    Evidence-Based Child Health: A Cochrane Review Journal

    Volume 7, Issue 3, May 2012, Pages: 1041–1154, Moises A Calderon, Martin Penagos, Aziz Sheikh, Giorgio W Canonica and Stephen Durham

    Article first published online : 3 MAY 2012, DOI: 10.1002/ebch.1851

  10. You have free access to this content
    PDE5 inhibitors: considerations for preference and long-term adherence

    International Journal of Clinical Practice

    Volume 67, Issue 8, August 2013, Pages: 768–780, W. B. Smith II, I. R. McCaslin, A. Gokce, S. H. Mandava, L. Trost and W. J. Hellstrom

    Article first published online : 22 JUL 2013, DOI: 10.1111/ijcp.12074

  11. Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses

    Intervention Review

    The Cochrane Library

    Ravindra B Belgamwar and Mark Fenton

    Published Online : 20 APR 2005, DOI: 10.1002/14651858.CD003729.pub2

  12. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Article first published online : 28 MAY 2008, DOI: 10.1002/mds.22133

  13. Which Is First? The Controversial Issue of Precedence in the Treatment of Male Sexual Dysfunctions

    The Journal of Sexual Medicine

    Volume 10, Issue 10, October 2013, Pages: 2359–2369, Emmanuele A. Jannini, Andrea M. Isidori, Antonio Aversa, Andrea Lenzi and Stanley E. Althof

    Article first published online : 7 OCT 2013, DOI: 10.1111/jsm.12315

  14. Meta-Analysis of the Efficacy and Safety of Zolmitriptan in the Acute Treatment of Migraine

    Headache: The Journal of Head and Face Pain

    Volume 48, Issue 2, February 2008, Pages: 236–247, Li-Chia Chen and Darren M. Ashcroft

    Article first published online : 27 DEC 2007, DOI: 10.1111/j.1526-4610.2007.01007.x

  15. Drug Delivery Challenges for the Pediatric Patient: Novel Forms for Consideration

    Pediatric Drug Development: Concepts and Applications

    Andrew E. Mulberg, Dianne Murphy, Julia Dunne, Lisa L. Mathis, Pages: 576–582, 2013

    Published Online : 31 JUL 2013, DOI: 10.1002/9781118312087.ch46

  16. 35th Annual Meeting of the International Continence Society, Montreal, Canada, 28th August–2nd September 2005

    Neurourology and Urodynamics

    Volume 24, Issue 5-6, 2005, Pages: 401–598,

    Article first published online : 26 JUL 2005, DOI: 10.1002/nau.20173

  17. A Step Toward Development of Printable Dosage Forms for Poorly Soluble Drugs

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 10, October 2013, Pages: 3694–3704, Dhara Raijada, Natalja Genina, Daniela Fors, Erik Wisaeus, Jouko Peltonen, Jukka Rantanen and Niklas Sandler

    Article first published online : 31 JUL 2013, DOI: 10.1002/jps.23678

  18. Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient

    The Journal of Sexual Medicine

    Volume 8, Issue 12, December 2011, Pages: 3418–3432, Giovanni Corona, Nicola Mondaini, Andrea Ungar, Elisa Razzoli, Andrea Rossi and Ferdinando Fusco

    Article first published online : 13 OCT 2011, DOI: 10.1111/j.1743-6109.2011.02473.x

  19. SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction

    The Journal of Sexual Medicine

    Volume 10, Issue 1, January 2013, Pages: 130–171, Hartmut Porst, Arthur Burnett, Gerald Brock, Hussein Ghanem, Francois Giuliano, Sidney Glina, Wayne Hellstrom, Antonio Martin-Morales, Andrea Salonia, Ira Sharlip and the ISSM Standards Committee for Sexual Medicine

    Article first published online : 23 JAN 2013, DOI: 10.1111/jsm.12023

  20. Dissolution testing of orally disintegrating tablets

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 7, July 2012, Pages: 911–918, Johannes Kraemer, Jayachandar Gajendran, Alexis Guillot, Julian Schichtel and Akif Tuereli

    Article first published online : 8 APR 2012, DOI: 10.1111/j.2042-7158.2012.01473.x